Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better. Resmed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for ...

Morgan Stanley analyst David Bailey maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – ...

ResMed Inc. (RMD), headquartered in San Diego, California, specializes in designing and delivering medical devices and ...

Read about CSL, Resmed and more in the latest Market Talks covering the Health Care sector.

The risk of both all-cause deaths and those caused by cardiovascular conditions in OSA patients is significantly reduced with the use of CPAP therapy.

EBR Systems, backed by investors such as HESTA, Hostplus and private equity veteran Mark Carnegie, can start selling its technology within months.

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor ...

ResMed Inc. closed 19.96% below its 52-week high of $263.05, which the company achieved on January 30th.

ResMed Inc. closed 18.65% short of its 52-week high of $263.05, which the company reached on January 30th.

SAN DIEGO – Resmed has announced that its home sleep apnea test, NightOwl, is now available across the U.S.

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

In a report released on April 10, Davinthra Thillainathan from Goldman Sachs maintained a Buy rating on Resmed Inc CHESS Depositary Interests ...